AIM
YARW

Axiom Investment Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Axiom Investment Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 426
2022
Q3 		$0 Buy
+1
New +$320 ﹤0.01% 464

Other funds holding YARW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Axiom Investment Management's YARW Position: Q4 2022 in Review

Axiom Investment Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q4 2022, closing a stake of 1 share.

Axiom Investment Management first reported a position in YARW in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 38 funds tracked by Wall St. Rank hold YARW as of Q4 2022.

  • Axiom Investment Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Axiom Investment Management sold 1 Yarrow Bioscience, Inc. Common Stock share in Q4 2022.
  • Axiom Investment Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Axiom Investment Management's Yarrow Bioscience, Inc. Common Stock position peaked at $0 in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.